Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05498090 · ClinicalTrials.gov registry record · Phase 4
Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome
A Phase 4 study of Klinefelter Syndrome, sponsored by University of Colorado, Denver.
- Active
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT05498090: Active Phase 4 study of Klinefelter Syndrome, sponsored by University of Colorado, Denver.
NCT05498090 is a Phase 4 study of Klinefelter Syndrome that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 44 participants, below the 278-participant average among 4 other Klinefelter Syndrome trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05498090, a Phase 4 study of Klinefelter Syndrome, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will learn more about how the body uses energy. Usually, the body uses sugars as energy first and then fats are used when the sugar stores are gone. Some people have trouble using fats as energy. This can lead to feeling tired, difficulty exercising, and storing too much fat where it does not belong (like in the muscle). It is believed that some boys and men with Klinefelter Syndrome may not be able to use fats as energy normally, and that a medication called fenofibrate could help this.
Conditions Studied
Interventions
- DRUG Fenofibrate 145 mg
Study Locations (1)
Colorado
- University of Colorado - Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2025-08-30 |
| Phase | Phase 4 |
What the registry record for NCT05498090 still lists
NCT05498090 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 278-participant average among 4 other Klinefelter Syndrome trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Klinefelter Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Fenofibrate 145 mg is the first listed.
NCT05498090 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05498090 about?
NCT05498090 is a clinical study titled "Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome". This study will learn more about how the body uses energy. Usually, the body uses sugars as energy first and then fats are used when the sugar stores are gone. Some people have trouble using fats as energy. This can lead to feeling tired, difficulty exercising, and storing too much fat where it does...
What is the current status of trial NCT05498090?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2022-11-03. Estimated completion is 2025-08-30.
What conditions does trial NCT05498090 study?
This clinical trial studies the following conditions: Klinefelter Syndrome.
What interventions are being tested in trial NCT05498090?
The interventions under investigation include: Fenofibrate 145 mg (DRUG).
Who is sponsoring clinical trial NCT05498090?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05498090 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Klinefelter Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
COMPLETED · Phase 4
-
The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy
RECRUITING
-
Cardiometabolic Profiles of Boys With Klinefelter Syndrome
COMPLETED
-
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI